A Clinical Trial To EvaluateThe Efficacy Of Abhaya VatakaIn The Management Of NonAlcoholic Fatty LiverDisease. - NI

I0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年7月22日

试验速览

暂无简介。

•Subjects, diagnosed with NAFLD according to the USG report, standard criteria accepted by the American Gastroenterology Association.
•Subjects diagnosed with Grade I & II Non Alcoholic Fatty liver Disease Subjects between the age of 18 and 60 years
•Subjects irrespective of gender and socio-economic status.
•Subjects who are willing to sign the consent form and agreeing to follow the
•protocol of the study.

•1) Subjects with history of alcohol intake more than 20 g/ day for women and more than 30g/day for men
•2) Diagnosed case of renal, respiratory, cardiovascular (including IHD), neurologic diseases, Hepatocellular carcinoma, and liver cirrhosis.
•3) Subjects with history of following drug intake -steroids, synthetic estrogens, heparin, and amiodarone, valproic acid, antiviral agents.
•4) Pregnant women, lactating mothers and mentally challenged persons.
•5) Uncontrolled Diabetes Mellitus and Hypertension.

发起方